{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:57:20Z","timestamp":1785761840680,"version":"3.56.0"},"reference-count":17,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Objectives<\/jats:title>\n<jats:p>Sudden sensorineural hearing loss patient outcomes remain highly variable despite established treatment modalities. This study investigates the effects of treatment modalities, individual-level risk factors, and clinical presentation on sudden sensorineural hearing loss recovery.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Retrospective chart review of n\u2009=\u2009231 patients who initiated intratympanic steroids between 01\/01\/2015-01\/01\/2025 following sudden sensorineural hearing loss. We collected individual-level risk factors and comprehensive audiometric data. Logistic and linear regression analyses were performed to identify relationships between patient, disease, and treatment-related variables to audiometric recovery (pure-tone average and word recognition score). Segmented linear regression analysis was used to assess the influence of intratympanic steroid treatment delay on patient recovery. Recovery outcomes were determined in accordance with American Academy of Otolaryngology-Head and Neck Surgery criteria.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Earlier intratympanic steroid initiation following sudden sensorineural hearing loss symptom onset significantly predicted increased pure-tone average recovery (p\u2009&lt;\u20090.001) irrespective of intratympanic steroid status as primary treatment or as salvage therapy following oral steroids. Intratympanic steroid efficacy significantly diminished if initiated beyond 18 days following symptom onset (p\u2009&lt;\u20090.001). Total number of intratympanic received and time between subsequent intratympanic injections did not impact recovery. Patient-level factors including demographics, socioeconomic status, medical and social risk factors, and medical comorbidities were largely found to have no significant relationship with recovery. Increased initial pure-tone average was associated with poorer overall pure-tone average recovery (p\u2009&lt;\u20090.001). The presence of initial serviceable hearing predicted worse final recovery status (p\u2009=\u20090.01). Bilateral sudden sensorineural hearing loss showed significantly worse pure-tone average recovery compared to unilateral sudden sensorineural hearing loss (p\u2009=\u20090.04).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Intratympanic steroids are an effective treatment option for sudden sensorineural hearing loss. Clinicians should be mindful of intratympanic steroid initiation timing and case-specific factors that may influence sudden sensorineural hearing loss recovery when treating patients with sudden sensorineural hearing loss.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0332809","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:27:03Z","timestamp":1760030823000},"page":"e0332809","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intratympanic steroid administration and predictors of recovery in sudden sensorineural hearing loss"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3516-5803","authenticated-orcid":true,"given":"Devin J.","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucienna","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquelyn","family":"Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Addison","family":"Lana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Wiefels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Pyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Yunis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5574-4387","authenticated-orcid":true,"given":"Michael","family":"Hoffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"issue":"9","key":"pone.0332809.ref001","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1097\/MAO.0000000000000222","article-title":"Incidence of sudden sensorineural hearing loss","volume":"34","author":"TH Alexander","year":"2013","journal-title":"Otol Neurotol"},{"key":"pone.0332809.ref002","article-title":"Clinical practice guideline: sudden hearing loss (update)","volume":"161","author":"SS Chandrasekhar","year":"2019","journal-title":"Otolaryngol\u2013Head Neck Surg"},{"issue":"1","key":"pone.0332809.ref003","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/lary.24834","article-title":"Steroids for treatment of sudden sensorineural hearing loss: a meta-analysis of randomized controlled trials","volume":"125","author":"RA Crane","year":"2015","journal-title":"Laryngoscope"},{"key":"pone.0332809.ref004","doi-asserted-by":"crossref","DOI":"10.1016\/j.anorl.2017.12.011","article-title":"International consensus (ICON) on treatment of sudden sensorineural hearing loss","volume":"135","author":"M Marx","year":"2018","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"pone.0332809.ref005","unstructured":"Available from: https:\/\/data.census.gov"},{"key":"pone.0332809.ref006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005537-199907001-00001","article-title":"Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application","volume":"109","author":"LS Parnes","year":"1999","journal-title":"Laryngoscope"},{"issue":"2","key":"pone.0332809.ref007","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.otohns.2005.05.015","article-title":"Intratympanic steroid injection for treatment of idiopathic sudden hearing loss","volume":"133","author":"WH Slattery","year":"2005","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"8","key":"pone.0332809.ref008","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1097\/MAO.0000000000000834","article-title":"Dose effect of intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss: 24\u2009mg\/mL is superior to 10\u2009mg\/mL","volume":"36","author":"TH Alexander","year":"2015","journal-title":"Otol Neurotol"},{"issue":"6","key":"pone.0332809.ref009","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/MAO.0000000000000450","article-title":"A prospective, multi-centered study of the treatment of idiopathic sudden sensorineural hearing loss with combination therapy versus high-dose prednisone alone: a 139 patient follow-up","volume":"35","author":"A Battaglia","year":"2014","journal-title":"Otol Neurotol"},{"issue":"1","key":"pone.0332809.ref010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.mlg.0000245058.11866.15","article-title":"Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy","volume":"117","author":"DS Haynes","year":"2007","journal-title":"Laryngoscope"},{"issue":"6","key":"pone.0332809.ref011","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00405-010-1476-8","article-title":"The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing loss","volume":"268","author":"JB Lee","year":"2011","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"3","key":"pone.0332809.ref012","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000320838","article-title":"Intratympanic methylprednisolone improves hearing function in refractory sudden sensorineural hearing loss: a control study","volume":"16","author":"P Li","year":"2011","journal-title":"Audiol Neurootol"},{"issue":"1","key":"pone.0332809.ref013","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MAO.0000000000001254","article-title":"Hearing changes after intratympanically applied steroids for primary therapy of sudden hearing loss: a meta-analysis using mathematical simulations of drug delivery protocols","volume":"38","author":"A Liebau","year":"2017","journal-title":"Otol Neurotol"},{"key":"pone.0332809.ref014","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1288\/00005537-198405000-00014","article-title":"Sudden hearing loss: eight years\u2019 experience and suggested prognostic table","volume":"94","author":"FM Byl","year":"1984","journal-title":"Laryngoscope"},{"issue":"5","key":"pone.0332809.ref015","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.otc.2004.04.004","article-title":"Intratympanic steroids for sensorineural hearing loss","volume":"37","author":"SD Rauch","year":"2004","journal-title":"Otolaryngol Clin North Am"},{"key":"pone.0332809.ref016","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/000348947708600406","article-title":"Natural history of sudden sensorineural hearing loss","volume":"86","author":"DE Mattox","year":"1977","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"1","key":"pone.0332809.ref017","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.otohns.2007.01.022","article-title":"Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy","volume":"137","author":"G Plaza","year":"2007","journal-title":"Otolaryngol Head Neck Surg"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0332809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:27:09Z","timestamp":1760030829000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0332809"}},"subtitle":[],"editor":[{"given":"Rafael da Costa","family":"Monsanto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":17,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0332809","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]}}}